Fungal antigens in intensive care units: available assays and current uses;Antigènes fongiques en réanimation : tests disponibles et état des lieux

Reanimation

Volumn 16, Issue 3, 2007, Pages 232-239

  Bretagne, S ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Fungal antigens; Galactomannan; Glucan; Intensive care unit; Mannan

Indexed keywords

BETA GLUCAN; FUNGUS ANTIGEN; GALACTOMANNAN; MANNAN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ASPERGILLOSIS; BLOOD SAMPLING; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC PROCEDURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INTENSIVE CARE UNIT; MYCOSIS; NONHUMAN; SCREENING; SCREENING TEST; SEROLOGY; SHORT SURVEY; STANDARDIZATION; YEAST;

EID: 34249735905     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2007.02.016     Document Type: Short Survey

References (51)

1. Gudlaugsson O., Gillespie S., Lee K., Vande Berg J., Hu J., et al. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37 (2003) 1172-1177
2. Azoulay E., Timsit J.F., Tafflet M., de Lassence A., Darmon M., et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 129 (2006) 110-117
3. Eloy O., Marque S., Botterel F., Stéphan F., Costa J.-M., et al. Uniform distribution of three Candida albicans microsatellite markers in two French ICU populations supports a lack of nosocomial cross-contamination. BMC Infect. Dis. 13 (2006) 162
4. Stephan F., Bah M.S., Desterke C., Rezaiguia-Delclaux S., Foulet F., et al. Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit, as studied using microsatellite markers. Clin. Infect. Dis. 35 (2002) 1477-1483
5. Casadevall A., and Pirofski L.A. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67 (1999) 3703-3713
6. Garnacho-Montero J., Amaya-Villar R., Ortiz-Leyba C., Leon C., Alvarez-Lerma F., et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit. Care 9 (2005) R191-R199
7. Vandewoude K.H., Blot S.I., Benoit D., Colardyn F., and Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J. Hosp. Infect. 56 (2004) 269-276
8. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34 (2002) 7-14
9. Meersseman W., Vandecasteele S.J., Wilmer A., Verbeken E., Peetermans W.E., and Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am. J. Respir. Crit. Care Med. 170 (2004) 621-625
10. Yeo S.F., and Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15 (2002) 465-484
11. Walsh T.J., Hathorn J.W., Sobel J.D., Merz W.G., Sanchez V., et al. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 324 (1991) 1026-1031
12. Sigmundsdottir G., Christensson B., Bjorklund L.J., Hakansson K., Pehrson C., and Larsson L. Urine D-arabinitol/L-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants. J. Clin. Microbiol. 38 (2000) 3039-3042
13. Stynen D., Goris A., Sarfati J., and Latge J.P. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. 33 (1995) 497-500
14. Maertens J., Verhaegen J., Demuynck H., Brock P., Verhoef G., et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J. Clin. Microbiol. 37 (1999) 3223-3228
15. Mennink-Kersten M.A., Donnelly J.P., and Verweij P.E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4 (2004) 349-357
16. Cordonnier C., Botterel F., Pautas C., Maury S., Kuentz M., and Bretagne S. Galactomannan antigenemia has a higher diagnostic yield in invasive aspergillosis in deeply neutropenic patients than in others. in 32nd EBMT meeting (2006), Germany, Hamburg
17. Pfeiffer C.D., Fine J.P., and Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42 (2006) 1417-1427
18. Verweij P.E., Weemaes C.M., Curfs J.H., Bretagne S., and Meis J.F. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J. Clin. Microbiol. 38 (2000) 3900-3901
19. Boutboul F., Alberti C., Leblanc T., Sulahian A., Gluckman E., et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin. Infect. Dis. 34 (2002) 939-943
20. Mennink-Kersten M.A., Klont R.R., Warris A., Op den Camp H.J., and Verweij P.E. Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection. Lancet 363 (2004) 325-327
21. Bart-Delabesse E., Basile M., Al Jijakli A., Souville D., Gay F., et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J. Clin. Microbiol. 43 (2005) 5214-5220
22. Dalle F., Charles P.E., Blanc K., Caillot D., Chavanet P., et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J. Clin. Microbiol. 43 (2005) 2929-2931
23. Rimek D., Zimmermann T., Hartmann M., Prariyachatigul C., and Kappe R. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses 42 Suppl 2 (1999) 25-28
24. Sendid B., Tabouret M., Poirot J.L., Mathieu D., Fruit J., and Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol. 37 (1999) 1510-1517
25. Rimek D., Singh J., and Kappe R. Cross-reactivity of the PLATELIA CANDIDA antigen detection enzyme immunoassay with fungal antigen extracts. J. Clin. Microbiol. 41 (2003) 3395-3398
26. Sendid B., Caillot D., Baccouch-Humbert B., Klingspor L., Grandjean M., et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J. Clin. Microbiol. 41 (2003) 4551-4558
27. Yera H., Sendid B., Francois N., Camus D., and Poulain D. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 864-870
28. Prella M., Bille J., Pugnale M., Duvoisin B., Cavassini M., et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn. Microbiol. Infect. Dis. 51 (2005) 95-101
29. Sendid B., Poirot J.L., Tabouret M., Bonnin A., Caillot D., et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 51 (2002) 433-442
30. Verduyn Lunel F.M., Voss A., Kuijper E.J., Gelinck L.B., Hoogerbrugge P.M., et al. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J. Clin. Microbiol. 42 (2004) 867-870
31. Sendid B., Jouault T., Coudriau R., Camus D., Odds F., et al. Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis. J. Clin. Microbiol. 42 (2004) 164-171
32. Fujita S., Takamura T., Nagahara M., and Hashimoto T. Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia. J. Med. Microbiol. 55 (2006) 537-543
33. Philip A., Odabasi Z., Matiuzzi G., Paetznick V.L., Tan S.W., et al. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J. Clin. Microbiol. 43 (2005) 4834-4835
34. Odabasi Z., Paetznick V.L., Rodriguez J.R., Chen E., McGinnis M.R., and Ostrosky-Zeichner L. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med. Mycol. 44 (2006) 267-272
35. Hashimoto A., Yamakami Y., Kamberi P., Yamagata E., Karashima R., et al. Comparison of PCR, (1-->3)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis. J. Clin. Lab. Anal. 12 (1998) 257-262
36. Mitsutake K., Miyazaki T., Tashiro T., Yamamoto Y., Kakeya H., et al. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J. Clin. Microbiol. 34 (1996) 1918-1921
37. Pickering J.W., Sant H.W., Bowles C.A., Roberts W.L., and Woods G.L. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43 (2005) 5957-5962
38. Odabasi Z., Mattiuzzi G., Estey E., Kantarjian H., Saeki F., et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39 (2004) 199-205
39. Pazos C., Ponton J., and Del Palacio A. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43 (2005) 299-305
40. Digby J., Kalbfleisch J., Glenn A., Larsen A., Browder W., and Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin. Diagn. Lab. Immunol. 10 (2003) 882-885
41. Dromer F, Lortholary O. Cryptococcose. Encyclopédie Médico-Chirurgicale 2004; 8: 613-1-10.
42. Nourry L., Gagnadoux F., Pierrot M., Gourdier A.L., Mercat A., and Racineux J.L. Aspergillose pulmonaire invasive compliquant un choc septique. Rev. Mal. Respir. 22 (2005) 806-810
43. Eggimann P., Garbino J., and Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3 (2003) 685-702
44. Sandven P., and Giercksky K.E. Yeast colonization in surgical patients with intra-abdominal perforations. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 475-481
45. Ibara A.-S., Morin O., Renard B., Millet S., Struillou L., and Villers D. Surveillance mycologique des patients à haut risque de candidose invasive: place de l'antigénémie mannane. Journal de Mycologie Médicale 14 (2004) 34-42
46. Eloy E., Marque S., Mourvilliers B., Pina P., Allouch P.-Y., et al. Intérêt de l'index de colonisation, de l'antigénémie mannane, des IgM et des anticorps totaux anti-Candida dans le diagnostic des candidoses invasives chez les patients de réanimation. Journal de Mycologie Médicale 16 (2006) 113-118
47. Lepper P.M., Wiedeck H., Geldner G., Essig A., and Trautmann M. Value of Candida antigen and antibody assays for the diagnosis of invasive candidosis in surgical intensive care patients. Intensive Care Med. 27 (2001) 916-920
48. Bar W., and Hecker H. Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies. Mycoses 45 (2002) 22-28
49. Pallavicini F., Izzi I., Pennisi M.A., Morace G., Portaccio G.G., et al. Evaluation of the utility of serological tests in the diagnosis of candidemia. Minerva Anestesiol. 65 (1999) 637-639
50. Takesue Y., Kakehashi M., Ohge H., Imamura Y., Murakami Y., et al. Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients. World J. Surg. 28 (2004) 625-630
51. Spiegelhalter D.J., and Best N.G. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat. Med. 22 (2003) 3687-3709